tiprankstipranks
Verona Pharma Plc (VRNA)
NASDAQ:VRNA
US Market

Verona Pharma (VRNA) Technical Analysis

Compare
718 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
0Neutral
7Bearish
Technical Analysis Consensus
Sell
3Bullish
0Neutral
7Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Verona Pharma Plc’s (VRNA) Moving Averages Convergence Divergence (MACD) indicator is 4.02, suggesting Verona Pharma Plc is a Sell.
Verona Pharma Plc’s (VRNA) 20-Day exponential moving average is 60.19, while Verona Pharma Plc’s (VRNA) share price is $67.96, making it a Buy.
Verona Pharma Plc’s (VRNA) 50-Day exponential moving average is 53.20, while Verona Pharma Plc’s (VRNA) share price is $67.96, making it a Buy.

Verona Pharma (VRNA) Pivot Points

Feb 22, 2025, 12:25 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
60.27
61.26
62.72
63.71
65.17
66.16
67.62
Fibonacci
61.26
62.19
62.77
63.71
64.64
65.22
66.16
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Verona Pharma (VRNA) Moving Averages

Feb 22, 2025, 12:25 PM
Period
Simple
Exponential
MA5
64.92Buy
64.99Buy
MA10
62.73Buy
63.21Buy
MA20
60.01Buy
60.19Buy
MA50
51.57Buy
53.20Buy
MA100
43.54Buy
45.55Buy
MA200
31.96Buy
34.74Buy
Verona Pharma Plc’s (VRNA) 10-Day exponential moving average is 63.21, while Verona Pharma Plc’s (VRNA) share price is $67.96, making it a Buy.
Verona Pharma Plc’s (VRNA) 100-Day exponential moving average is 45.55, while Verona Pharma Plc’s (VRNA) share price is $67.96, making it a Buy.
Verona Pharma Plc’s (VRNA) stock price is $67.96 and Verona Pharma Plc’s (VRNA) 50-day simple moving average is 51.57, creating a Buy signal.
Verona Pharma Plc’s (VRNA) stock price is $67.96 and Verona Pharma Plc’s (VRNA) 100-day simple moving average is 43.54, creating a Buy signal.
Verona Pharma Plc’s (VRNA) stock price is $67.96 and Verona Pharma Plc’s (VRNA) 200-day simple moving average is 31.96, creating a Buy signal.

Verona Pharma (VRNA) Technical Indicators

Feb 22, 2025, 12:25 PM
Name
Value
Implied Action
RSI (14)
76.88
Sell
STOCH (9,6)
86.53
Sell
STOCHRSI (14)
89.30
Sell
MACD (12,26)
4.02
Sell
ADX (14)
59.59
Sell
Williams %R
-5.14
Sell
CCI (14)
157.68
Sell
ATR (14)
2.81
-
Ultimate Oscillator
70.18
Buy
ROC
18.60
Buy
Verona Pharma Plc’s (VRNA) Relative Strength Index (RSI) is 76.88, creating a Sell signal.
Verona Pharma Plc’s (VRNA) Trend Strength Indicator (ADX) is 59.59, creating a Sell signal.
Verona Pharma Plc’s (VRNA) Commodity Channel Index (CCI) is 157.68, creating a Sell signal.
Verona Pharma Plc’s (VRNA) Price Rate of Change (ROC) is 18.60, creating a Buy signal.

FAQ

Is VRNA a Buy, Hold, or Sell?
Based on VRNA’s technical indicators, VRNA is a Buy.
    What is VRNA’s RSI (14)?
    VRNA’s RSI (14) is 76.88, which suggests VRNA is a Sell.
      What is VRNA’s MACD?
      VRNA’s MACD is 4.02, which suggests VRNA is a Sell.
        What is VRNA’s 5-day moving average?
        VRNA’s 5-day moving average is 64.92, which suggests VRNA is a Buy.
          What is VRNA’s 20-day moving average?
          VRNA 20-day moving average is 60.01, which suggests VRNA is a Buy.
            What is VRNA’s 50-day moving average?
            VRNA’s 50-day moving average is 51.57, which suggests VRNA is a Buy.
              What is VRNA’s 200-day moving average?
              VRNA’s 200-day moving average is 31.96, which suggests VRNA is a Buy.
                What is VRNA’s Williams % R (14)?
                VRNA’s Williams % R (14) is -5.14, which suggests VRNA is a Sell.
                  What is VRNA’s CCI (14)?
                  VRNA’s CCI (14) is 157.68, which suggests VRNA is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis